CHK9 increased the expression of proapoptotic (Bax) protein and decreased the expression of STAT3-target proteins and tumor suppressor (p53) protein (Figure 5), indicating the apoptosis modulatory effect of CHK9 in lung cancer cells. Here, BAX is linked to lung carcinoma.